Legal Representation
Attorney
JAMES R MEYER
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 19, 2011 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Jan 11, 2010 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 11, 2010 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Jun 9, 2009 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 17, 2009 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 25, 2009 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Feb 10, 2009 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 10, 2009 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jan 30, 2009 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 30, 2009 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 30, 2009 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 30, 2009 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 30, 2009 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 8, 2009 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 8, 2009 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 8, 2009 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 5, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 5, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 5, 2008 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 5, 2008 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 17, 2008 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
| Oct 16, 2008 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, collagenase enzyme used to treat fibroproliferative disease conditions, namely, Dupuytren's contracture, Peyronie's disease and frozen shoulder syndrome also known as adhesive capsulitis
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of a rectangle with the word mark "XIAFLEX" in blue on a white background in the center with an orange design completing the "A" and "F" with the wording "CLOSTRIDIAL COLLAGENASE FOR INJECTION" in black below "XIAFLEX" and below all the wording appears a larger horizontal wave design having, from top to bottom, bands of orange, blue and tan colors.
Color Claim
The color(s) blue, black, orange and tan is/are claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"CLOSTRIDIAL COLLAGENASE FOR INJECTION"